Natera Inc Stock
Your prediction
Pros and Cons of Natera Inc in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Natera Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Natera Inc | 0.520% | -4.000% | 7.865% | 19.255% | 26.316% | 402.618% | - |
| Atricure Inc. | - | 2.367% | 23.571% | -44.194% | -44.194% | -44.194% | -13.500% |
| Orasure Tech | 0.970% | -3.738% | 7.292% | -44.624% | -39.766% | -56.356% | -77.730% |
| SI-BONE Inc | -1.830% | 1.863% | 10.067% | 26.154% | 26.154% | - | - |
News
Natera (NTRA) Q2 Revenue Jumps 32%
Natera (NASDAQ:NTRA), a leader in genetic testing across oncology, women's health, and organ health, reported its earnings for Q2 2025 on August 7, 2025. The most significant news was a 32.2%
